Healthcare & Medical Devices Global On demand · 24-48h

Global Polyglucose and Sodium Chloride Injection Market Strategic Research Report

Global Polyglucose and Sodium Chloride Injection Market Stra…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Polyglucose and Sodium Chloride Injection Market
$30.252025
5.9%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: 500ml: 60g Condensed Glucose and 4.25g Sodium Chloride, 250ml: 30g Condensed Glucose and 2.125g Sodium Chloride

By Application: Hospital, Clinic, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Peking University Pharmaceutical Co., Ltd., Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd., Chongqing Dikang Changjiang Pharmaceutical Co., Ltd., Zhejiang Guojing Pharmaceutical Co., Ltd., Sichuan Kelun Pharmaceutical Co., Ltd., Shijiazhuang Siyao Co., Ltd., Huiyinbi Group Jiangxi East Asia Pharmaceutical Co., Ltd., Yichang Three Gorges Pharmaceutical Co., Ltd.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 102 pages
Market size 2025
$30.25
Million USD
Forecast CAGR
5.9%
2025-2032
Forecast 2032
$45.2
Projected
リージョン
5
Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global Polyglucose and Sodium Chloride Injection market size is predicted to grow from US$ 30.25 million in 2025 to US$ 44.95 million in 2032; it is expected to grow at a CAGR of 5.9% from 2026 to 2032.

Polyglucose and Sodium Chloride Injection is an aqueous solution containing glucose and sodium chloride, which is mainly used to replenish water, electrolytes and energy in the body. It combines the immediate energy source provided by glucose with the role of sodium chloride in maintaining body fluid osmotic pressure and electrolyte balance. It is suitable for adjuvant treatment of patients with dehydration, hypoglycemia or electrolyte disorders caused by various reasons, such as postoperative, severe vomiting and diarrhea, malnutrition, etc. The injection is given by intravenous infusion and can be quickly absorbed and utilized by the body to help restore physiological functions and stabilize the internal environment.

Global key Polyglucose and Sodium Chloride Injection players cover Peking University Pharmaceutical Co., Ltd., Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd., Chongqing Dikang Changjiang Pharmaceutical Co., Ltd., Zhejiang Guojing Pharmaceutical Co., Ltd., Sichuan Kelun Pharmaceutical Co., Ltd., etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Polyglucose and Sodium Chloride Injection market?

What factors are driving Polyglucose and Sodium Chloride Injection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Polyglucose and Sodium Chloride Injection market opportunities vary by end market size?

How does Polyglucose and Sodium Chloride Injection break out by Type, by Application?

This report presents a comprehensive overview of the global Polyglucose and Sodium Chloride Injection market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • 500ml: 60g Condensed Glucose and 4.25g Sodium Chloride
  • 250ml: 30g Condensed Glucose and 2.125g Sodium Chloride

Segment by Application

  • Hospital
  • Clinic
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Polyglucose and Sodium Chloride Injection market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Clinic, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Polyglucose and Sodium Chloride Injection Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.9%
Regional growth momentum
Market share by segment
Key metrics
Base value
$30.25
2025
Forecast
$45.2
2032
CAGR
5.9%
2025–2032
リージョン
5
global
Key companies
Peking University Pharmaceutical Co., Ltd.Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd.Chongqing Dikang Changjiang Pharmaceutical Co., Ltd.Zhejiang Guojing Pharmaceutical Co., Ltd.Sichuan Kelun Pharmaceutical Co., Ltd.Shijiazhuang Siyao Co., Ltd.Huiyinbi Group Jiangxi East Asia Pharmaceutical Co., Ltd.Yichang Three Gorges Pharmaceutical Co., Ltd.
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
500ml: 60g Condensed Glucose and 4.25g Sodium Chloride250ml: 30g Condensed Glucose and 2.125g Sodium Chloride
By Application
HospitalClinicOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 500ml: 60g Condensed Glucose and 4.25g Sodium Chloride
  • 3.1.3 250ml: 30g Condensed Glucose and 2.125g Sodium Chloride
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Clinic
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Peking University Pharmaceutical Co., Ltd.
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd.
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Chongqing Dikang Changjiang Pharmaceutical Co., Ltd.
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Zhejiang Guojing Pharmaceutical Co., Ltd.
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Sichuan Kelun Pharmaceutical Co., Ltd.
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Shijiazhuang Siyao Co., Ltd.
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Huiyinbi Group Jiangxi East Asia Pharmaceutical Co., Ltd.
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Yichang Three Gorges Pharmaceutical Co., Ltd.
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Polyglucose and Sodium Chloride Injection market?
The global Polyglucose and Sodium Chloride Injection market is estimated at US$ 30.25 million in 2025 (base year) and is projected to reach US$ 44.95 million by 2032.
How fast is the Polyglucose and Sodium Chloride Injection market expected to grow?
The market is expected to grow at a CAGR of 5.9% from 2026 to 2032, expanding from US$ 30.25 million in 2025 to US$ 44.95 million in 2032, roughly 1.5 times its base-year value.
What does the Polyglucose and Sodium Chloride Injection market cover?
Polyglucose and Sodium Chloride Injection is an aqueous solution containing glucose and sodium chloride, which is mainly used to replenish water, electrolytes and energy in the body. It combines the immediate energy source provided by glucose with the role of sodium chloride in maintaining body fluid osmotic pressure and electrolyte balance. It is suitable for adjuvant treatment of patients with dehydration, hypoglycemia or electrolyte disorders caused by various reasons, such as postoperative, severe vomiting and diarrhea, malnutrition, etc.
How is the Polyglucose and Sodium Chloride Injection market segmented by type?
By type, the market is segmented into 500ml: 60g Condensed Glucose and 4.25g Sodium Chloride and 250ml: 30g Condensed Glucose and 2.125g Sodium Chloride.
What are the key applications of Polyglucose and Sodium Chloride Injection?
Key applications covered include Hospital, Clinic and Other.
Which companies are profiled in the Polyglucose and Sodium Chloride Injection market report?
Key players profiled include Peking University Pharmaceutical Co., Fuzhou Haiwang Fuyao Pharmaceutical Co., Chongqing Dikang Changjiang Pharmaceutical Co., Zhejiang Guojing Pharmaceutical Co., Sichuan Kelun Pharmaceutical Co., Shijiazhuang Siyao Co., Huiyinbi Group Jiangxi East Asia Pharmaceutical Co. and Yichang Three Gorges Pharmaceutical Co..
What geographies does the Polyglucose and Sodium Chloride Injection market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Polyglucose and Sodium Chloride Injection?
What factors are driving Polyglucose and Sodium Chloride Injection market growth, globally and by region?
Who should buy the Polyglucose and Sodium Chloride Injection market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital, Clinic and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Polyglucose and Sodium Chloride Injection market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.